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Abstract 
For many years, the intestine was one of the poor relations of the immunology world, being 
a realm inhabited mostly by specialists and those interested in unusual phenomena. 
However this has changed dramatically in recent years with the realisation of how 
important the microbiota is in shaping immune function throughout the body and almost 
every major immunology institution now includes the intestine as an area of interest. One of 
the most important aspects of the intestinal immune system is how it discriminates carefully 
between harmless and harmful antigens, in particular its ability to generate active tolerance 
to materials such as commensal bacteria and food proteins. This phenomenon has been 
known for more than 100 years and it is essential for preventing inflammatory disease in the 
intestine, but its basis remains enigmatic. Here, I discuss the progress that has been made in 
understanding ‘oral tolerance’ during my 40 years in the field and highlight the topics that 
will be the focus of future research. 
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Introduction 
The intestine has a long history as an immunological organ, with its lymphocytes and 
organised lymphoid tissues having been discovered many years ago, even if their functions 
were not fully understood at the time. When I started in the field more than 40 years ago, it 
was already known that there were more lymphocytes in the intestine than in any other 
part of the body, which of course makes complete sense when one considers its constant 
exposure to microbes and other external antigens. However until very recently, intestinal 
immunology was neglected by mainstream immunologists. The gut was held to be a dirty 
and complicated tissue that was difficult to work with and where experimental findings 
were at best phenomenology rather than precise data of immunological importance. This 
attitude has been transformed in recent years, in great part because of the realisation that 
the intestinal microbiota plays a crucial role in shaping immune function and susceptibility 
to disease. As a result, the intestine is now seen as a fulcrum of the immune system and 
there is increasing interest in exploring its unusual aspects and understanding how these 
might influence immunity elsewhere.  
One of the most characteristic and longest known features of the intestinal immune 
system is its ability to develop tolerance to the wealth of harmless foreign antigens it 
encounters on a routine basis and yet still generate active immunity against pathogens. As 
well as being fundamental to understanding the pathogenesis of inflammatory bowel 
diseases and to creating orally active vaccines, this balancing act in the intestinal immune 
system is also the best physiological example of how innate immune signals are constantly 
being integrated to regulate adaptive immune responses. I first became fascinated by this 
phenomenon as a medical student in the mid 1970s when carrying out an elective project 
with the late Anne Ferguson, whose research interest was in coeliac disease and who was 
then at the forefront of the emerging field of mucosal immunology. After completing a PhD 
with Anne, immune regulation in the intestine has continued to be the focus of my research 
ever since. In this Timeline article, I will provide a personal perspective on the key 
discoveries that have shaped our current understanding of immunological tolerance in the 
intestine, often referred to simply as ‘oral tolerance’ (Figure 2). Strictly speaking however, 
this term should be used only for the local and systemic hyporesponsiveness to subsequent 
challenge which occurs when exogenous antigens are administered by the oral route. This is 
one aspect of the more general phenomenon of ‘mucosal tolerance’ that characterizes the 
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failure of all steady state mucosal surfaces to make effector responses against harmless 
materials of all kinds.  
 
 
Oral tolerance – historical aspects 
The first serious interest in the intestine as an immunological organ came about because of 
the epidemics of typhoid, cholera and other intestinal infections that were prevalent when 
microbiology and immunology were developing as disciplines in the late 19th century. At this 
time, sporadic attempts were made to vaccinate individuals orally with relevant 
microorganisms, some of which were partially successful. However it also became apparent 
from these kinds of experiments that non-living materials were ineffective in inducing active 
immunity in the intestine. In 1911, Wells & Osborne demonstrated that oral administration 
of proteins such as ovalbumin (OVA) prevented subsequent local and systemic anaphylactic 
reactions to these proteins in guinea pigs1. By 1930, it had been shown that prior feeding of 
contact-sensitizing agents prevented dermal hypersensitivity to these agents — the 
Sulzberger–Chase phenomenon2. Even at this early stage, the experimental tolerance that 
was induced by oral administration of antigens was found to be antigen specific and 
evidence was then obtained that tolerised lymphocytes were rendered intrinsically and 
permanently unresponsive3. However it was not until 1994 that the ability of orally 
administered antigens to induce systemic tolerance was demonstrated formally in humans, 
when feeding the novel antigen keyhole limpet haemocyanin (KLH) was found to inhibit 
subsequent delayed type hypersensitivity (DTH) responses after skin challenge4.  
   
Mechanisms of oral tolerance to protein antigens. 
What became known as ‘oral tolerance’ was first explored in immunological detail in the 
1970s and 1980s, when its scope and mechanistic basis were documented. Amongst the 
insights that emerged were that the oral route of antigen delivery was a particularly 
efficient way of inducing tolerance5. It also became clear that soluble antigens such as 
proteins were able to induce tolerance when given orally, whereas antigens in the form of 
particles or as part of a live organism were more likely to provoke active immunity. Even 
though these studies were conducted before the importance of the innate immune system, 
costimulation and ‘danger signals’ had been appreciated, they were already seen as 
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evidence that tolerance reflected an inability to activate the antigen presentation limb of 
the immune response in such a way that lymphocytes were not primed properly5. It was 
also shown that while oral tolerance could affect all aspects of the immune response, it was 
particularly effective at inhibiting responses that could cause damage to the host, such as T 
cell-mediated DTH reactions and IgE-dependent responses. Thus the idea was already 
forming that tolerance to harmless antigens in the intestine was a physiologically crucial 
phenomenon designed to prevent pathological conditions directed at, for example, food 
proteins5.  
The tolerance described in these early studies could be transferred to naive animals 
by lymphocytes and as with many other aspects of immune regulation at the time, it was 
proposed that this was dependent on a population of CD8+ ‘suppressor T cells’; oral 
tolerance could also be prevented by depleting such cells in vivo6. However this aspect of 
immunology collapsed dramatically in the late 1980s, as increasing knowledge of T cell 
biology and MHC restriction indicated there was no molecular basis for antigen-specific 
CD8+ T cells to function in this way. Indeed the original observations implicating this 
population have never been explained satisfactorily in the intervening years, and in the 
1990s, attention turned to the emerging immunoregulatory mechanisms that involved CD4+ 
T cells.  
A debate in cellular immunology at this time was whether cell intrinsic mechanisms 
such as clonal deletion and anergy could account for tolerance in T cells, or whether this 
involved extrinsic control by active inhibitory mechanisms. In the 1990s, Howard Weiner 
and colleagues proposed that which of these mechanisms was involved in oral tolerance 
might be determined by the antigen dose regime used. Whereas single high doses of protein 
antigen were thought to cause anergy and/or deletion of antigen-specific T cells [Au:OK?] , 
multiple feeds of lower doses were predicted to generate regulatory T (Treg) cells7. This was 
important because of the ideas that arose around this time of harnessing oral tolerance for 
treating immunological diseases (see below). Specifically, it was considered that active Treg 
cells would be more useful for this purpose. This was because of their ability to persist and 
to produce cytokines that would generate ‘bystander’ suppression by acting on effector T 
cells with different specificities, something which would help overcome the epitope 
spreading that is a feature of many autoimmune disorders. Although some evidence was 
presented that clonal deletion of antigen-specific T cells could be induced in oral tolerance, 
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this was found after feeding very large doses of antigen to full T cell receptor (TCR) 
transgenic mice, a system that was unlikely to represent the usual situation in vivo8. In 
general, it was never proven experimentally that clonal deletion and/or anergy could 
contribute to oral tolerance in the presence of a polyclonal T cell repertoire using 
physiological amounts of antigen. Indeed subsequent experiments suggest that the higher 
the dose of antigen fed, the better the induction of Treg cells9.  
 
Treg cells enter the fray. 
In common with other aspects of immune regulation, most studies of oral tolerance in the 
last 20 years have focused on the possible role of T cells with active inhibitory properties 
and in particular, CD4+ Treg cells. Before this subset itself was defined, regulation of T cell 
function in oral tolerance was proposed to be an example of the Th1/Th2 paradigm that 
dominated cellular immunology for some time. This was an attractive idea, as oral tolerance 
seemed to be particularly effective in suppressing DTH responses and it was thought that 
this might be due to preferential activation of Th2 cells7. However this could not explain why 
IgE production, which is a signature Th2 cell-mediated function, was also very easy to 
tolerize by feeding antigen. As a result, the paradigm was modified to accommodate 
findings that a population of transforming growth factor β (TGFβ)-secreting CD4+ T cells (at 
the time proposed to be ‘Th3’ cells) was associated with oral tolerance10. Again these cells 
were never characterized in full and this work was conducted before the discovery of the 
transcription factor forkhead box protein P3 (FOXP3), or what we would now consider as 
bona fide Treg cells. The first evidence supporting a role for such cells in oral tolerance came 
from studies using surrogate markers for Treg cells, such as CD25, showing that tolerance 
could be transferred by CD4+ T cells co-expressing these surrogate markers [Au:OK?] 11-14. 
Control of oral tolerance by FOXP3+ Treg cells was eventually shown directly in 200715 and 
has since been confirmed in different systems16,17. Indeed, it seems that most ‘inducible’ 
Treg cells in the steady state small intestine may be specific for food antigens17. The 
mechanism of action for these cells is usually assumed to involve production of TGFβ, but as 
yet there is little direct evidence for this.  
 
 
The intestinal microbiota 
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The presence of bacteria in the normal intestine has been known from the start of 
microbiology as a discipline and their contribution to host metabolism and other aspects of 
health has been appreciated for many years. For instance, germ-free animals have very 
reduced immune responses and much smaller lymphoid organs18, 19. An obvious problem 
for immunologists is how the immune system could cope with this enormous burden of 
foreign antigen without attempting to ‘reject’ it. The simplistic assumption that the 
microbes were simply not visible to immune cells became untenable when it was shown 
that the large amount of secretory IgA antibodies present in the normal intestine is directed 
mostly at the bacteria that make up the microbiota20. Indeed, it was then suggested that 
one of the principal roles of IgA was to prevent access of commensal bacteria to the body 
(the concept of ‘immune exclusion’21) and in support of this, subsequent studies have 
shown that a substantial proportion of commensal bacteria in the colon are coated with 
IgA22. In the mid 1990s, the ground-breaking studies of Fiona Powrie and others showed the 
normal immune system also contains effector T cells that could recognise the 
microbiota23,24. However these are normally kept in check by Treg cells, which were shown 
to act via the production of IL-1025 or TGFβ26, consistent with the spontaneous colitis that 
had been found in IL-10-deficient mice when they were first described27.  
Unlike the situation with protein antigens encountered in the gut, tolerance to the 
gut microbiota is compartmentalized to the intestine and the systemic immune system is 
essentially ignorant of its presence28 (Figure 2). The explanation for this comes from earlier 
experiments by the group of Andrew Macpherson which showed that recognition of 
microbiota-derived antigens is dependent on uptake by dendritic cells (DCs) that migrate no 
further than the mesenteric lymph nodes (MLNs)29. As a result, specific immune responses 
to the microbiota are localised to the intestinal mucosa and involve the generation of Treg 
cells and secretory IgA production. Studies of the mechanisms underlying IgA class-switching 
and the induction of Treg cells indicated that a common factor could be the cytokine TGFβ 
and it has been suggested subsequently that Treg cells may themselves drive IgA production 
in response to the microbiota30,31, possibly becoming follicular helper T cells (TFH) in Peyer’s 
patches32. Compartmentalisation of tolerance to the microbiota makes complete biological 
sense, as these organisms are highly pathogenic if they escape into body from the intestinal 
lumen and therefore it is important that protective immunity can be generated under these 
circumstances. There are several processes that restrict access of the microbiota to the 
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systemic immune system, including the physical barriers presented by the mucus layer and 
intact epithelium, as well as the innate immune defences that protect the epithelial barrier 
(see below). 
Despite the intact organisms that make up the microbiota being kept at bay, one of 
the biggest developments in immunology in my time has been the recognition of how the 
microbiota shape immune responses both in the intestine and elsewhere. The first example 
of an individual organism having this kind of effect was the ability of Segmented 
Filamentous Bacteria (SFB) to drive IgA production33 and several years later, SFB was found 
to be the main factor responsible for inducing TH17 cell responses in mice34,35. Subsequent 
examples include the induction of IL-10-producing Treg cells by polysaccharide A from 
Bacteroides fragilis36 and the ability of certain human Clostridial spp. to expand FOXP3+ Treg 
cells via the local production of TGFβ and butyrate [Au: It might be worth mentioning / 
citing one or two of the studies from Honda’s group that have actually associated specific 
human microbiota strains with the induction of Treg cells and Th1 cells e.g. I’m thinking of 
K Atarashi et al Science. 2017 Oct 20;358(6361):359-365, Atarashi et al. Nature. 2013 Aug 
8;500(7461):232-6. doi: 10.1038/nature12331.]37 38 39. It is now accepted that these effects 
of the microbiota are not restricted to the intestine, and that microbiota at various tissue 
sites influence many aspects of biology throughout the body, including susceptibility to 
numerous diseases40. Furthermore, the intestine is by no means the only source of 
commensal micro-organisms and without doubt, these topics will be one of the main areas 
of research into the foreseeable future.  
 
 
DCs and intestinal tolerance 
 
Migratory DCs create a tolerogenic environment.  
One of the unresolved questions about oral tolerance to protein antigens is how the 
phenomenon can affect both local and systemic immune responses, raising the issue of 
where antigen is taken up and presented to T cells. The discovery of microfold (‘M’) cells in 
Peyer’s patches and their ability to transport antigen into the immune system41 led to the 
assumption that this would be the route for inducing oral tolerance. Indeed, the first formal 
demonstration of ‘suppressor T cells’ in oral tolerance described these cells in Peyer’s 
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patches42, while both clonal deletion of antigen-specific T cells and CD4+ T cells with 
inhibitory properties were subsequently described in the Peyer’s patches of protein-fed 
mice8,43. Nevertheless a number of studies have shown that surgical or developmental 
removal of Peyer’s patches does not alter the induction of oral tolerance to proteins (see 44 
for review) and in recent years, attention has turned more to the idea that the relevant 
antigen is acquired by DCs in the villus lamina propria and transported by these cells to the 
draining MLNs where the induction of Treg cells occurs (Figure 2).  
Studies by the groups of Oliver Pabst and others have confirmed that both the 
migration of DCs and the induction of oral tolerance are dependent on CC-chemokine 
receptor 7 (CCR7) and suggested that events in MLNs drive the systemic consequences of 
tolerance45,46. However it is not known how the MLNs can influence the immune system 
outwith the intestine. Furthermore, the earliest studies in which antigen-specific CD4+ T 
cells could be tracked directly found that orally administered antigen was detected by T cells 
simultaneously throughout the immune system (that is, by both peripheral and mucosal T 
cells) and not only in the MLNs44. This systemic dissemination of antigen was consistent with 
work from the 1980s showing that ingested proteins are present in an immunologically 
relevant form in the circulation of healthy humans and mice5,47,48. In mice this material was 
shown to be tolerogenic when transferred to normal recipients and together these findings 
could explain the systemic consequences of oral tolerance without a specific role for the 
MLNs. While these apparent contradictions have not yet been explained, it seems quite 
possible that both processes may contribute to oral tolerance to soluble antigens, with their 
relative importance perhaps depending, for instance, on the dose, size and nature of the 
antigen.  
A further issue that has never been resolved is whether the liver plays any role in the 
systemic consequences of oral tolerance. This is an attractive idea, as materials emanating 
from the intestine in the bloodstream drain directly to the liver via the portal vein and direct 
administration of antigen into the portal vein induces a state of systemic tolerance that 
appears to be rather similar to oral tolerance49. However older experiments in which 
tolerance was prevented when the portal circulation was disrupted or when Kupffer cells 
were depleted using the heavy metal gadolinium have proved difficult to interpret due to 
toxicity issues49. Similarly, the studies suggesting that liver sinusoidal endothelial cells 
(LSECs)50 or plasmacytoid DCs51 might act as tolerogenic antigen-presenting cells (APCs) for 
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oral antigens still await full explanation. This is an area which deserves revisiting with more 
modern and precise approaches, such as the recently described marker Clec4F that allows 
highly selective deletion of Kupffer cells in vivo 52. 
While accepting these uncertainties, the current consensus is that the DCs present in 
the lamina propria play a crucial role in determining immune responsiveness to protein 
antigens in the intestine (Figure 2); the characterization of these cells has been a central 
focus of many groups in mucosal immunology in the past 10 years, including my own. In 
large part, this reflects the advances in flow cytometry and molecular biology that now 
allow small populations of cells from tissues to be analysed in depth. Nevertheless it is 
interesting to put this in context with the fact that the intestine was one of first tissues in 
which MHCII+ ‘dendritic cells’ were identified when research into such cells was in its 
infancy53. Later work showed that expansion of DC numbers in vivo using the Fms-related 
tyrosine kinase 3 ligand (FLT3L) growth factor could enhance the induction of oral tolerance 
and in fact this was one of the first demonstrations that DCs could induce tolerance as well 
as priming effector responses in the immune system54.  
The first experiments using DCs isolated from the intestine described a population in 
Peyer’s patches that produced IL-10 selectively55. This was followed by findings that 
CD11c+MHCII+ APCs could be isolated from the small intestinal lamina propria of antigen-fed 
mice and that these APCs induced tolerance to the fed antigen when transferred into 
recipients that had not been exposed to the antigen56. As with much other work at that 
time, the precise identification of these mucosal DCs became complicated by the realisation 
that they shared many markers with macrophages and it was not until very recently that it 
was shown using definitive markers that bona fide conventional DCs are required for the 
induction oral tolerance57. In the meantime, it had been shown that CD103 was expressed 
by most lamina propria DCs58, although much earlier studies had inadvertently used CD103 
to identify DCs migrating in lymph from the intestinal mucosa in rats59. The newly defined 
CD103+ DCs in mice were found to be responsible for the uptake of orally administered 
antigen60 and to preferentially promote the generation of Treg cells in vitro via their 
selective production of retinoic acid (RA) that acted in cooperation with TGFβ. For these 
reasons, intestinal CD103+ DCs were then held to be intrinsically ’tolerogenic’ DCs — and to 
be the major drivers of tolerance in the intestine61-63. More recently however, this field has 
been complicated by the findings that CD103+ DCs in the intestine are heterogeneous in 
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nature; while some have the CD103+CD11b-SIRPα- phenotype of the cross-presenting, IRF8- 
and BATF3-dependent ‘cDC1’ found in other tissues64-66, the majority of CD103+ DCs in the 
small intestine is CD103+CD11b+SIRPα+. As discussed below, these are related to the IRF4-
dependent CD11b+SIRPα+ ‘cDC2’ found elsewhere, although they are essentially unique to 
the intestine in steady state conditions (reviewed in 67). Further complexity comes from the 
fact that there is an additional population of CD103-CD11b+ DCs in the intestinal lamina 
propria; these also produce RA, but are less effective at inducing Treg cells in vitro. In the 
past, less rigorous gating strategies had referred to this last population with macrophages, 
but they are clearly distinct, by being F4/80-CD64- and expressing DC-specific molecules 
such as FLT3 and the zinc finger transcription factor ZBTB4668.  
It is still unclear exactly which of these DC subsets is responsible for oral tolerance, 
although very recent results suggest that the IRF8-dependent CD103+CD11b- DCs are not 
involved in the case of soluble antigens57 and that this may be driven mostly by 
CD103+CD11b+ DCs in the small intestine69. Interestingly, there is evidence for anatomical 
differences for DC subset involvement, with CD103-CD11b+ DC appearing to be responsible 
for tolerance to soluble antigens in the colon69. Furthermore, CD103+CD11b- DC seem to be 
the most effective subset at driving the induction of FOXP3+ Treg cells in vitro via RA 
production [Au:OK?] and are also the only mucosal DC subset that can activate TGFβ via 
expression of the αvβ8 integrin67,70,71. Identifying the DC involved in the induction of oral 
tolerance is one of the important challenges for the future, as will be establishing the role of 
specific regulatory molecules such as IL-10, TGFβ, RA or indoleamine dioxygenase (IDO) in 
this process72. Finally, the finding that migratory DCs can transport commensal bacteria to 
the MLN (see above) has not yet been translated into definitive studies of which DC subset 
might be responsible for establishing and maintaining [Au:OK? Or are you just referring to 
the induction of tolerance?] tolerance to the microbiota; in future, more precise 
approaches should enable the identification of these cells and establish whether there are 
distinct roles for DCs and macrophages [Au:OK? I didn’t quite follow you here – is this what 
you are trying to get at?] . 
 
Acquisition of antigen by intestinal DCs. 
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Several mechanisms have been suggested over the years for how antigen might get access 
to DCs in the lamina propria, which is rather a puzzle, considering that the epithelial barrier 
is supposed to be impermeable to macromolecules (Figure 3). However as noted above, 
there is evidence for the presence of intact proteins in serum after antigen feeding, while 
some immunohistochemical studies have suggested that epithelial cells might deliver 
peptide products of digestion into the lamina propria73. Epithelial cell-derived exosomes 
have also been proposed to deliver tolerogenic materials from the intestinal lumen into the 
underlying network of immune cells in the lamina propria74. Work using more refined 
techniques has since attempted to address the issue at the cellular level, with the first 
intravital microscopy studies proposing that a population of ‘DCs’ could extend processes 
across the epithelium to capture antigen from the lumen75,76. However, it now seems that 
the cells involved may well have been macrophages rather than DCs, as they expressed a 
combination of CD11c, MHCII and CX3C-chemokine receptor 1 (CX3CR1), a typical 
macrophage pattern. Using more refined identification approaches, subsequent intravital 
microscopy studies have shown that a specific transport pathway associated with goblet 
cells may allow access of protein antigens to underlying CD103+ DC in the lamina propria 
and that this process is necessary for oral tolerance77. However, other work using similar 
techniques has suggested that CD103+ DCs may completely enter the epithelial layer and 
thus sample luminal contents directly78. This would be consistent with earlier in vitro work 
using cell lines, which showed DCs entering epithelial monolayers and forming tight 
junctions with the surrounding cells, thus avoiding disruption of the barrier79. However the 
role of this process in oral tolerance has not yet been demonstrated. A similar proviso 
applies to the finding that the conventional villus epithelium may contain a population of M 
cells with the potential to sample and transport antigen80. Lastly, an intriguing study 
updated the potential involvement of CX3CR1+ macrophages in oral tolerance, presenting 
evidence that these were indeed the principal cell type involved in the uptake of proteins 
from the lumen, but that they then transferred antigen to CD103+ DCs via connexin 43-
dependent gap junctions81. As macrophages do not migrate to MLNs in steady state 
conditions, it is likely that this transfer process must occur locally in the lamina propria 
itself.  
Thus these diverse technical approaches have not yet generated a consensus on how 
antigen gains access to intestinal DCs and importantly, few studies have correlated events in 
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the mucosa with subsequent immune responses. Of equal note, current immunohistological 
techniques have not yet allowed the subsets of DCs and macrophages present in the 
intestine [Au: should you specify ‘present in the intestine’ or ‘involved in oral tolerance’ 
here?] to be delineated with sufficient precision in situ. 
 
Local conditioning determines DC function. 
A question of intense interest is what drives the unusual properties of intestinal DCs, such as 
the exclusive expression of CD103 by cDC2s in the intestine, their production of RA and their 
apparently tolerogenic phenotype. An obvious possibility is that these characteristics are 
dependent on the local tissue environment. The first evidence to support this idea came 
from experiments showing that human monocyte-derived DCs that were conditioned with 
supernatant from the Caco-2 colonic epithelial cell line could mimic the ability of isolated 
colonic DCs to produce IL-10 and drive the generation of Th2 cells in vitro. This was due to 
the presence of thymic stromal lymphopoietin (TSLP) in the supernatant, a mediator also 
expressed by colonic epithelial cells in the steady state82. Similar work then implicated TGFβ 
in the ability of epithelial cells to block inflammatory cytokine production by DCs83.  
Around the same time, attention began to focus on the role of RA, not just as a 
mediator of intestinal DC function, but as a factor controlling their differentiation. 
Exogenous RA was first shown to induce a ‘mucosal’ DC phenotype in mouse bone marrow-
derived DCs as assessed by their ability to drive RA-dependent processes in T and B cells, 
such as expression of CCR9, α4β7 and IgA class-switching84. This evidence that RA is 
important for its own production by DCs was subsequently confirmed, although the exact 
source of the conditioning RA is not yet clear, as both epithelial cells85 and stromal cells86,87 
have been implicated. The primary source of retinol, from which RA is derived, is dietary 
vitamin A and the delivery of retinol to lamina propria DCs in the small intestine is enhanced 
by its high concentration in bile, reflecting storage of retinol in the liver88. As well as 
inducing its own production, RA may be responsible for other features of intestinal DCs, 
including their anti-inflammatory properties and ability to drive FOXP3+ Treg cell 
differentiation in vitro89,90. Indeed recent studies propose that there is a specific precursor 
in the bone marrow for intestinal CD103+CD11b+ and CD103+CD11b- DC whose development 
is dependent on RA91.  
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One of the most unusual aspects of the intestine is the presence of substantial 
numbers of CD103+CD11b+ DCs (see 67 for review). These are not found in other steady state 
tissues, where the expression of CD103 is restricted to DCs belonging to the cross-
presenting population of BATF3- and IRF8- dependent XCR1+ cDC1s92. Within a short time of 
being discovered, a number of studies showed that intestinal CD103+CD11b+ DCs were 
related to the lineage of cDC2s that expresses SIRPα, being dependent on Notch 2, IRF4 and 
Krüppel-like factor 4 (KLF4) for their development. Other factors that are involved include 
GM-CSF, SIRPα and RA. However, most of these processes are generic to the cDC2 lineage92 
and there clearly must be something distinctive about the intestinal mucosa that accounts 
for the unusual properties of the cDC2s in this site. In very recent studies, we have found 
that CD103 expression is only one of many features that differentiate CD103+CD11b+ DCs 
from other CD11b+ DCs93. These include the expression of TREM1, SiglecF, glycoprotein 2 
(GP2) and CD101, as well as a distinct cassette of genes. By using these markers to 
interrogate CD11c-Cre-TGFβR1flox/flox mice, we were able to uncover a cell intrinsic and gut-
specific role for TGFβ signalling in driving the local differentiation of CD103+CD11b+ DCs 
from a CD103-CD11b+ intermediary93. Further work is required to determine how TGFβ 
might interact with other mediators in specifying the development of these DCs and to 
establish its source in vivo. One such factor may be granulocyte-macrophage colony-
stimulating factor (GM-CSF), which is needed for CD103+CD11b+ DCs to develop and one 
intriguing idea is that this may be produced by one of the other recently discovered 
populations of intestinal immune cell, the type 3 innate lymphoid cell (ILC3)94. 
 
 
Maintenance of tolerance in the mucosa 
Soluble protein antigens. 
Once tolerance has been induced in the MLNs or Peyer’s patches, several mechanisms 
operate in the mucosa itself to ensure this homeostatic state is maintained. Treg cells that 
differentiate first in the secondary lymphoid organs exit and migrate to the lamina propria 
via efferent lymphatics and blood (Figure 2). As with other lymphocytes whose first 
encounter with antigen occurred in the intestinal lymphoid tissues, it was found that Treg 
cell homing to the small intestine requires the induction of α4β7 integrin and CCR9 
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expression on these cells by RA-producing DCs95. In parallel, oral tolerance to protein 
antigens was shown to be defective in mice lacking these homing molecules95. An important 
insight into what might regulate the behaviour of Treg cells once they arrive in the small 
intestinal lamina propria came from studies by Oliver Pabst’s group, which showed that IL-
10 produced from CX3CR1+ lamina propria macrophages was needed to maintain local 
expansion of the FOXP3+ Treg cell populations involved in oral tolerance to proteins16. 
Intriguingly, this study also concluded that some of the Treg cell populations that expand in 
the lamina propria then leave the mucosa and are responsible for the systemic 
consequences of oral tolerance (Figure 2). While this idea would be consistent with older 
work showing that antigen-experienced CD4+ T cells are present in efferent lymph coming 
from the intestine96, it remains to be proven directly. 
 
The microbiota. 
As noted above, it has been known for many years that IL-10 is also important for 
maintaining tolerance to microbiota in the large intestine. With the discovery that 
macrophages in the colonic lamina propria produce substantial amounts of IL-10 
constitutively97 and the findings that lamina propria macrophages could drive the 
generation of FOXP3+ Treg cells in vitro98,99, it seemed sensible to suggest that macrophage-
derived IL-10 would be the critical factor in preventing intestinal inflammation. However, 
recent work has challenged this idea, by showing that whereas conditional deletion of the 
IL-10R in macrophages in CX3CR1-Cre-IL10Rflox/flox mice leads to spontaneous colitis, deletion 
of IL-10 itself in macrophages does not100. This supports earlier work showing that LysM-
Cre-Stat3flox/flox mice (in which macrophages cannot respond to IL-10) also develop 
spontaneous intestinal inflammation [Au:OK? Or ‘colitis’? To answer the referee’s 
comment]101. Thus it appears that signalling via the IL-10R on macrophages is needed to 
maintain tolerance to the microbiota, whereas other cells, probably CD4+ T cells, are 
responsible for producing the IL-10. A further recent idea to explain the lack of a local 
inflammatory response to the microbiota is that MHCII+ ILC3s may induce cell death in 
microbiota-specific CD4+ T cells, although this possibility remains to be confirmed102. The 
mechanisms governing the migration of microbiota-specific Treg cells to the colon are still 
not understood in any detail, although recently it was proposed that the G protein coupled 
receptor GPR15 might fulfil this role103. 
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Intestinal disease 
In the past 20 years, it has become widely accepted that when tolerance in the intestine 
fails, this leads to inflammatory disease. As discussed above, the first indication that this 
was the case following loss of tolerance to the microbiota came when it was found that Il10-
/- mice developed spontaneous IBD and that this was dependent on the presence of 
commensal bacteria27. More recently, it was shown that non-functional mutations in IL10 or 
its receptor pathway in humans lead to early-onset IBD104. Many subsequent studies in mice 
have confirmed that a breakdown in the processes that underpin symbiosis between the 
host and its microbiota can lead to IBD40. The first studies examining genetic susceptibility to 
Crohn’s disease showed an association between non-functional mutations in NOD2 and ileal 
Crohn’s disease105,106. Since then, Crohn’s disease has become one of the best understood 
inflammatory disorders at the genetic level, with most susceptibility genes coding for factors 
involved in innate defence mechanisms used by myeloid cells and the epithelial barrier to 
deal with bacteria. These include Card9, Il23r, TNF-SF15, ATG16L1 that promotes autophagy 
in Paneth cells and the autophagy related IRGM gene (reviewed in 107). 
 The equivalent conditions that occur when tolerance to protein antigens breaks 
down are coeliac disease and food allergies. Starting with seminal work in the 1990s and 
2000s showing that α-gliadin-specific CD4+ effector T cells could be cloned from the mucosa 
of untreated patients with coeliac disease but not from healthy individuals108, evidence 
accumulated for gliadin-dependent inflammatory changes in coeliac intestine, involving 
IFNγ109,110, IL-21111 and type 1 interferons (IFNs)112. Substantial progress in understanding 
the immunopathogenesis of coeliac disease was also made around the same time, with the 
main antigenic peptides in gliadin being identified and their molecular interactions with the 
disease-specific HLA-DQ2 molecule being elucidated, together with the essential role of the 
tissue transglutaminase (tTG) in generating the peptides113,114. Despite this wealth of 
knowledge on the clinical disorder, it has never been shown directly that there is a defect in 
specific regulatory mechanisms such as Treg cells and there is still no fully satisfactory 
experimental model of coeliac disease. As a PhD student, I found that some aspects of the 
intestinal pathology such as crypt hyperplasia and increased numbers of intraepithelial 
lymphocytes could be reproduced in experimental animals by oral challenge with protein 
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antigen after oral tolerance had been prevented5. This work has been extended in the last 
15 years by findings that activation of the innate immune system by IL-15 may be an 
important mechanism allowing tolerance to be overcome. Together with RA, IL-15 may 
favour the generation of effector rather than regulatory CD4+ T cells and also activates 
cytotoxic activity by intestinal epithelial lymphocytes (IELs), leading to epithelial cell death 
and increased uptake of antigenic peptides115-118. Several studies have followed up initial 
work in 2003 that a non-epitope peptide within α-gliadin (p31-43) itself may trigger the 
release of IL-15119,120, with the most recent suggestions being that either p31-43121 or 
reovirus infection122 may drive TLR7- and/or TLR8- mediated release of type 1 IFN and 
innate immunity. These new insights have considerable implications for understanding the 
pathogenesis of coeliac disease as well as of other human autoimmune diseases of which 
coeliac disease is an excellent model. 
 IgE-mediated food allergies are amongst the diseases that have increased most in 
incidence in the last 40 years and here there is more direct evidence for a breakdown in oral 
tolerance. For instance it has been known for some time that spontaneous remission from 
cow’s milk allergy in children is accompanied by restoration of Treg cell numbers to normal 
levels123. Very recently, a substantial clinical trial showed that early exposure to peanut in 
the diet protected against the development of peanut-induced food allergy in at risk 
children, clearly suggesting that oral tolerance had been induced by this protocol124. 
Interestingly, it has long been known that the induction of oral tolerance to prevent IgE 
responses [Au:OK?] against protein antigens in mice requires signals derived from the 
microbiota125, perhaps partly explaining how exposure to antibiotics early in life may lead to 
enhanced susceptibility to atopic disease126.  
 
 
Oral tolerance-based therapy 
A number of animal models in the 1980s and 1990s suggested that oral tolerance might be 
exploited in the treatment of autoimmune disease, as feeding appropriate antigens was 
shown to prevent or even ameliorate established disease in experimental arthritis, type 1 
diabetes, encephalomyelitis and other models of autoimmunity7. As well as targeting 
antigen-specific T cells directly, this approach was thought to have the advantage of 
inducing Treg cells that might inhibit the phenomenon of epitope spreading via their ability 
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to produce bystander suppression of other T cell clones, as already discussed above. On the 
basis of the promising animal work, clinical trials were carried out in the 1990s examining 
the use of oral tolerance in rheumatoid arthritis, multiple sclerosis, autoimmune uveitis and 
type 1 diabetes127. However none of the trials were successful and this idea has not been 
resurrected since. While it remains an attractive possibility, difficulties in identifying the 
appropriate auto-antigens and in establishing regimes that will interfere with established 
disease may well prevent this becoming reality for autoimmune diseases. However the 
recent work on peanut allergy and coeliac disease indicate there could be scope in 
exploiting what appears to be a natural window for tolerance induction early in life for 
preventing disorders caused by inappropriate responses, for example, to food proteins.  
 
Summary 
Systemic tolerance to innocuous antigens was one of the first aspects of the intestinal 
immune system that was identified and it is now accepted that it plays a crucial role in 
preventing disorders such as coeliac disease, inflammatory bowel diseases and food 
allergies. While we still do not understand the process in full, recent years have seen a 
number of important advances based on the rapid expansion of knowledge in cellular 
immunology. In the case of soluble antigens such as food proteins, it is now clear that the 
induction of tolerance requires specific populations of DCs that express CD103 and produce 
retinoic acid. It is likely that these DCs are derived from the villus lamina propria, where they 
acquire antigen by routes that are yet to be defined, before migrating in lymph to meet 
naïve T cells in the draining mesenteric lymph node. Retinoic acid from the DCs drives the 
expression of gut homing markers on T cells and induces their differentiation into FOXP3+ 
Tregs that recirculate back to the mucosa and maintain tolerance via the production of IL-10 
and/or TGFβ. Mucosal macrophages may help maintain the local survival of Tregs via the 
production of IL-10. The cellular events involved in tolerance to the microbiota are less 
clear, but the process appears to be limited to the intestine itself and IL-10 clearly plays a 
crucial role in preventing inflammation to these antigens. In return, one of the most 
important developments in the field in the past 20 years has been the realisation that the 
microbiota has dramatic effects on immune function throughout the body. Extending these 
insights at the cellular and molecular level provides ample scope for research into the 
foreseeable future (Box 1). 
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Display items: 
 
Box 1: Future questions for the field 
• How do soluble antigens induce generalised tolerance, whereas tolerance to the 
microbiota is restricted to the intestine? 
• Are the cellular mechanisms of tolerance the same for these different forms of 
antigen? 
• Do discrepancies between these processes relate to anatomical differences in the 
immune systems of the small and large intestine? 
• What is the exact nature of the dendritic cells responsible for inducing tolerance and 
what molecular processes are involved in their interaction with T cells? 
• What factor(s) drive the differentiation of the specialised dendritic cells found in the 
intestine? 
• How do mucosal dendritic cells acquire antigen from the lumen? 
• Are FoxP3+ regulatory T cells alone responsible for tolerance and what is their 
mechanism of action? 
• Do MHCII expressing macrophages play a role in maintaining tolerance by 
presentation of cognate antigen to local CD4+ T cells? 
• How can fundamental insights from mouse models be translated into the 
understanding of diseases such as coeliac disease and inflammatory bowel disease?  
• Will oral tolerance be exploitable for treatment of autoimmune and inflammatory 
diseases? 
• How does the microbiota and its products shape oral tolerance and systemic 
immunity and what are the consequences of antibiotic use early in life on these 
processes? 
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Figure 2: Induction and maintenance of oral tolerance  
Soluble antigens such as food proteins are likely to be taken up predominantly into DCs in 
villus lamina propria, either directly by CD103+CD11b+ cDC2, or after phagocytic uptake of 
epithelial cells that have ingested antigen before dying by apoptosis. In this case, 
CD103+CD11b- cDC1 will be the DC involved71,128. Both these subsets of DC migrate 
constitutively in afferent lymph to the draining mesenteric lymph node, where they meet 
naïve CD4+ and CD8+ T cells. Production of retinoic acid by the DCs during the cognate 
interaction with T cells induces the expression of FoxP3, together with the gut homing 
molecules CCR9 and α4β7 integrin, leading to the generation of regulatory T cells capable of 
returning to the intestinal mucosa. The generation of Treg is also promoted by the presence 
of TGFβ, which can be converted from its latent, inactive form (iTGFβ) to the active cytokine 
(aTGFβ) via the action of αvβ8 integrin expressed selectively by CD103+CD11b- DCs71. After 
leaving the MLN, CD4+ FoxP3+ Treg migrate to the lamina propria via efferent lymph and the 
bloodstream. Here they prevent the activation of naïve and effector T cells via the 
expression of CTLA-4 that removes CD80/CD86 from antigen presenting cells and by 
production of the cytokines IL10 and TGFβ which inhibit both APC and T cells. IL10 produced 
by resident CX3CR1hi macrophages helps maintain FoxP3 expression by CD4+ Treg in the 
mucosa and is needed for their survival16,99. As these macrophages also express high levels 
of MHCII, they may also be able to undergo cognate interactions with specific CD4+ FoxP3+ 
Treg providing a second signal for survival, but this has not been shown directly as yet. 
Similarly, it has been hypothesised, but not proven, that CD4+ FoxP3+ Treg that have been 
primed in the MLN and passed through the mucosa may be involved in the systemic 
consequences of oral tolerance to protein antigens, requiring them to have exited the 
mucosa in lymph and migrated throughout the body via the bloodstream16. An alternative 
explanation for systemic tolerance is that orally administered antigens can be found in 
lymph and the bloodstream, gaining access to resident DCs in mesenteric and peripheral 
lymph nodes47 129. These DCs remain to be characterised, but could induce tolerance in CD4+ 
T cells via anergy or deletion, or by generating Treg due to the lack of costimulation that 
characterises secondary lymphoid organs in the steady state. 
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Commensal microbes gain access to the immune system mainly by transcytosis via M cells in 
the epithelium of Peyer’s patches and isolated lymphoid follicles. The antigens are then 
transferred to underlying DCs, probably belonging to the CD103-CD11b+ subset of cDC2. 
These DCs may then present antigen directly to naïve CD4+ T cells in the PP/ILF, or after 
migration to the draining MLN. Although this generates FoxP3+ Treg that can migrate to the 
mucosa and have similar properties to those induced by soluble antigens, the roles of RA, 
TGFβ and other DC subsets in these processes is unclear. An additional feature of the 
immune response to microbial antigens is the production of IgA antibodies. This is driven by 
CD4+ follicular helper T cells that interact with B cells in germinal centres of PP/ILF, inducing 
a switch to IgA expression mediated by TGFβ, IL5, IL6, ICOS, CD40L and other factors. Recent 
evidence suggests that some of these TFH may be derived from FoxP3+ Treg that have 
migrated into the germinal centre30 31. IgA switched B cells acquire CCR9 and α4β7 integrin, 
exit from PP/ILF via lymph and then migrate in bloodstream to arrive in the lamina propria 
as plasma cells. Unlike soluble antigens, the tolerance to microbial antigens is confined to 
the intestine and the systemic immune system normally remains ‘ignorant’ of these 
materials28. 
 
Figure 3: Models of antigen delivery for the induction of oral tolerance 
Antigens in the intestinal lumen can gain access to the immune system either via organised 
lymphoid tissues such as Peyer’s patches or isolated lymphoid follicles (ILF). Microfold (M) 
cells in the epithelial layer of PP or ILF transport microbes and particles to dendritic cells 
that lie wrapped in the basal membrane of the M cell (the M cell “pocket”), or that are in 
the underlying subepithelial dome region. A variety of routes have been proposed for the 
access of antigens across the villus epithelium, although this remains a controversial topic. 
Intact proteins may be transported directly across or between enterocytes, while rare 
populations of M cells have also been described outside Peyer’s patches80. Enterocytes may 
also capture and internalize antigen:antibody complexes by means of the neonatal Fc 
receptor (FcRn) on their surface and transport them across the epithelium by 
transcytosis130. At the basal face of the epithelium, lamina propria dendritic cells expressing 
FcRn and other Fc receptors pick up and internalize the complexes. Enterocytes that have 
apoptosed either due to senescence or after infection by a pathogen can be phagocytosed 
 23
by neighnbouring dendritic cell. CX3CR1+ mononuclear phagocytes have been shown to 
acquire luminal antigen efficiently and this may involve extension of processes between the 
cells of the epithelium without disturbing its integrity 75. Although these cells are likely to be 
macrophages that cannot present antigen directly to naïve T cells, they can then pass the 
antigen on to neighboring CD103+ dendritic cells for presentation to T cells, perhaps via 
Connexin 43 (Cx43) -mediated gap junctions81. Mucus secreting goblet cells can act as a 
conduit for delivery of soluble antigens to lamina propria CD103+ dendritic cells and this 
process appears to be important for oral tolerance77. CD103+ dendritic cells themselves 
might also enter the epithelial layer and capture bacteria before returning to the lamina 
propria131. 
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